Jin Medical International
ZJYL
ZJYL was delisted on the 31st of July, 2026.
10 hedge funds and large institutions have $1.5M invested in Jin Medical International in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
0% more ownership
Funds ownership: 0.06% → 0.06% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
17% less funds holding
Funds holding: 12 → 10 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
69% less capital invested
Capital invested by funds: $4.79M → $1.5M (-$3.29M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$296K |
| 2 |
Two Sigma Investments
New York
|
+$51.4K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$14.3K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.24K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WG
Winton Group
London,
United Kingdom
|
-$209K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$27.4K |
| 3 |
Morgan Stanley
New York
|
-$2.76K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.76K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $1.13M | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $149K | +$296K | +9,446 | +8,996% |
|
|
3
Invesco
Atlanta,
Georgia
| $98.9K | -$1.76K | -56 | -0.9% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $82.9K | – | – | – |
|
|
5
Two Sigma Investments
New York
| $25.5K | +$51.4K | +1,640 | New |
|
|
6
Osaic Holdings
Scottsdale,
Arizona
| $10.9K | +$14.3K | +455 | +186% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $3.1K | +$6.24K | +199 | New |
|
|
8
Morgan Stanley
New York
| $264 | -$2.76K | -88 | -84% |
|
|
BIA
9
Bell Investment Advisors
Oakland,
California
| $119 | – | – | – |
|
|
W
10
WealthCollab
Bellevue,
Washington
| $18 | – | – | – |
|
|
WG
11
Winton Group
London,
United Kingdom
| – | -$209K | -3,876 | Closed |
|
|
SSA
12
Schonfeld Strategic Advisors
New York
| – | -$27.4K | -510 | Closed |
|
|
13
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -32 | Closed |
|
14
BNP Paribas Financial Markets
Paris,
France
| – | -$417 | -8 | Closed |
|
ZJYL Hedge Fund Activity: Q4 2024 in Review
10 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q4 2024, worth a combined $1.5M — down 69% from $4.79M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ZJYL and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $296K. The largest seller was Winton Group, exiting entirely with an estimated $209K sold.
- 10 institutional investors held Jin Medical International (ZJYL) as of Q4 2024, down from 12 in Q3 2024.
- Funds reported $1.5M of Jin Medical International stock for Q4 2024, down 69% quarter-over-quarter.
- 2 funds opened new Jin Medical International positions in Q4 2024 and 4 closed out, a net change of -2 holders.
- The largest Jin Medical International buyer in Q4 2024 was UBS Group, an estimated $296K added.
- The largest Jin Medical International seller in Q4 2024 was Winton Group, an estimated $209K sold.
Based on aggregated 13F filings for Q4 2024.